Unique

ROS1 proto-oncogene case report crizotinib molecular targeted therapy non-small cell lung cancer

Journal

SAGE open medical case reports
ISSN: 2050-313X
Titre abrégé: SAGE Open Med Case Rep
Pays: England
ID NLM: 101638686

Informations de publication

Date de publication:
2022
Historique:
received: 15 12 2021
accepted: 21 04 2022
entrez: 27 5 2022
pubmed: 28 5 2022
medline: 28 5 2022
Statut: epublish

Résumé

Chromosomal rearrangements involving the c-ros oncogene 1 (

Identifiants

pubmed: 35619747
doi: 10.1177/2050313X221100407
pii: 10.1177_2050313X221100407
pmc: PMC9127844
doi:

Types de publication

Case Reports

Langues

eng

Pagination

2050313X221100407

Informations de copyright

© The Author(s) 2022.

Déclaration de conflit d'intérêts

Declaration of conflicting interests: The author(s) declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: M.F.S.A.R. has received support for attending meetings and travel expenses from Foundation Medicine. K.P.S. has received support for attending meetings and travel expenses from Astra-Zeneca. She has also received honoraria from Eurofarma. All other authors have no conflicts of interest to declare.

Références

Am J Surg Pathol. 2021 Dec 1;45(12):1707-1719
pubmed: 34001695
J Thorac Oncol. 2017 Nov;12(11):1611-1625
pubmed: 28818606
Oncologist. 2021 Jun;26(6):e908-e912
pubmed: 33682977
J Thorac Oncol. 2020 Dec;15(12):1880-1892
pubmed: 32931935
J Thorac Oncol. 2020 Jan;15(1):22-28
pubmed: 31864550
Ann Oncol. 2019 Jul 1;30(7):1121-1126
pubmed: 30980071
Lancet Oncol. 2020 Feb;21(2):261-270
pubmed: 31838015
Lung Cancer. 2019 Apr;130:201-207
pubmed: 30885345
J Thorac Oncol. 2020 Jun;15(6):948-961
pubmed: 32036070
N Engl J Med. 2014 Nov 20;371(21):1963-71
pubmed: 25264305
Cell. 2007 Dec 14;131(6):1190-203
pubmed: 18083107
PLoS One. 2011 Jan 06;6(1):e15640
pubmed: 21253578
Oncol Res. 2019 Aug 8;27(8):901-910
pubmed: 30940295
Cancer Discov. 2018 Oct;8(10):1227-1236
pubmed: 30093503
Transl Lung Cancer Res. 2020 Dec;9(6):2686-2695
pubmed: 33489827
NPJ Precis Oncol. 2021 Sep 10;5(1):81
pubmed: 34508169
Clin Lung Cancer. 2020 Jan;21(1):15-20
pubmed: 31607443
JTO Clin Res Rep. 2020 Feb 19;1(1):100015
pubmed: 34589917
Proc Natl Acad Sci U S A. 1987 Dec;84(24):9270-4
pubmed: 2827175
J Thorac Oncol. 2020 Dec;15(12):1800-1802
pubmed: 33246591
J Biol Chem. 2002 Mar 29;277(13):11107-15
pubmed: 11799110

Auteurs

Maurício Fernando Silva Almeida Ribeiro (MFSA)

Oncology Center, Hospital Sírio-Libanês, São Paulo, Brazil.

Luiza Lara Gadotti (LL)

Oncology Center, Hospital Sírio-Libanês, São Paulo, Brazil.

Karina Perez Sacardo (KP)

Oncology Center, Hospital Sírio-Libanês, São Paulo, Brazil.

Carlos Diego Holanda Lopes (CDH)

Oncology Center, Hospital Sírio-Libanês, São Paulo, Brazil.

Rodrigo Saddi (R)

Oncology Center, Hospital Sírio-Libanês, São Paulo, Brazil.

João Victor Machado Alessi (JVM)

Oncology Center, Hospital Sírio-Libanês, São Paulo, Brazil.

Mariana Petaccia de Macedo (MP)

Department of Pathology, Hospital Sírio-Libanês, São Paulo, Brazil.

Ellen Caroline Toledo do Nascimento (ECT)

Department of Pathology, Hospital Sírio-Libanês, São Paulo, Brazil.

Leonardo de Abreu Testagrossa (LA)

Department of Pathology, Hospital Sírio-Libanês, São Paulo, Brazil.

Artur Katz (A)

Oncology Center, Hospital Sírio-Libanês, São Paulo, Brazil.

Classifications MeSH